Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Profound Medical (PROF) Non-Current Deffered Revenue (2023 - 2025)

Profound Medical (PROF) has 3 years of Non-Current Deffered Revenue data on record, last reported at $388000.0 in Q4 2025.

  • For Q4 2025, Non-Current Deffered Revenue rose 691.84% year-over-year to $388000.0; the TTM value through Dec 2025 reached $388000.0, up 691.84%, while the annual FY2025 figure was $388000.0, 691.84% up from the prior year.
  • Non-Current Deffered Revenue reached $388000.0 in Q4 2025 per PROF's latest filing, up from $148000.0 in the prior quarter.
  • Across five years, Non-Current Deffered Revenue topped out at $728000.0 in Q4 2023 and bottomed at $49000.0 in Q4 2024.
  • Average Non-Current Deffered Revenue over 3 years is $245333.3, with a median of $116500.0 recorded in 2025.
  • Peak YoY movement for Non-Current Deffered Revenue: plummeted 93.27% in 2024, then skyrocketed 691.84% in 2025.
  • A 3-year view of Non-Current Deffered Revenue shows it stood at $728000.0 in 2023, then tumbled by 93.27% to $49000.0 in 2024, then surged by 691.84% to $388000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Non-Current Deffered Revenue were $388000.0 in Q4 2025, $148000.0 in Q3 2025, and $74000.0 in Q2 2025.